Crossmark

Perampanel treatment in Early-onset Epileptic Encephalopathy with infantile movement disorders associated with a de novo GRIN1 gene mutation: a 3-year follow-up

Crossref DOI link: https://doi.org/10.1007/s10072-020-04935-z

Published Online: 2021-01-05

Published Print: 2021-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dicanio, Daniela

Nicotera, Antonio Gennaro https://orcid.org/0000-0002-0847-2243
Cucinotta, F.

Di Rosa, G.
License Information

Text and Data Mining valid from 2021-01-05

Version of Record valid from 2021-01-05
More Information

Article History

Received: 7 August 2020

Accepted: 21 November 2020

First Online: 5 January 2021

Change Date: 28 January 2021

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s10072-021-05084-7

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Updates are available Correction dated 2021-01-28

Click to view Correction: https://doi.org/10.1007/s10072-021-05084-7